268209-50-3

Upstream product

• 268209-15-0 tert-butyl 4-(4-((S)-5-(aminomethyl)-2-oxooxazolidin-3-yl)-2-fluorophenyl)piperazine-1-carboxylate 

Downstream Products

• 268208-30-6 (S)-t-butyl 4-(2-fluoro-4-(5-((methoxycarbonothioylamino)methyl)-2-oxo-oxazolidin-3-yl)phenyl)piperazine-1-carboxylate 

Relevant academic research and scientific papers

NOVEL COMPOUNDS AND THEIR USE

The present invention provides novel compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof. The novel compounds are useful as antibacterial agents in the treatment of conditions such as nosocomial pneumonia, community acquired pneumonia, infections caused by vancomycin resistant enterococci (VRE), methicillin resistant Staphylococcus aureus (MRSA), Heamophilus influenzae (HI) and penicillin resistant Streptococcus pneumoniae (PRSP). The compounds of the present invention are effective against a number of human or animal pathogens including VRE, PRSP, HI and MRSA.